SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (89)5/6/1998 9:49:00 PM
From: Richard Haugland  Read Replies (3) of 359
 
I have no real information but I speculate that ABSC might be perceived as having difficulties on delivering what it has promised and this may be of concern to people in the know. I hope this is not true since I am quite long but it could be. Also, in discussions with others, I believe that ABSC has limited by contract the number of companies that it will "play with" and to which it will license its technology other than to approach the entire high-throughput screening market. It may have few if any remaining contracts to announce. Obviously, positive results should help this company, which has very competent scientists and a lot of promise. However, delivering ultra high-throughput screening results may be their challenge and possible downfall.

Pthers may know better about the structure and limitations of their agreements.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News